2-N-Boc-3-(3-Bromo-phenyl)-2-methylaminomethyl-propionic acid, 97.0%, 100mg

N-methoxy-N-methyl-2-phenylacetamide, 95.0%, 5g

1-((4-Hydrazinylbenzyl)sulfonyl)pyrrolidine hydrochloride, 95.0%, 1g

Methyl 2-Methoxy-5-nitrobenzoate>98.0%(GC)5g

N-(6-Oxo-5,6-dihydro-4H-cyclopenta[d]thiazol-2-yl)acetamide, 98%, 5g

6,6-Difluoro-3-azabicyclo[3.1.0]hexane hydrochloride, 95.0%, 5g

N-(2-(2-(2-(3-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamido)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 90%, 1g

2-((Benzyloxy)imino)acetic acid, 97%, 1g

Zinc foil 99.99+% 0.1 x 100 x 200 mm 1 pc

Adenosine 5'-monophosphate xsodium salt, 95.0%, 25g

O-(3-METHOXYBENZYL)HYDROXYLAMINE HCL, 95.0%, 25g

Microliter syringe GASTIGHT® series 1000, 10.0 ml, 1010 TLL, 1 piece

3,3',6,6'-Tetrabromo-9,9'-bicarbazole, 95%, 1g